Fig. 3.
Number of passing leukocytes per minute, percentage of rolling leukocytes, and number of adherent leukocytes per square millimeters on the hamster window chamber microcirculation. Data are given as means ± SD. CONTROL, baseline controls (n = 5); SALINE–SALINE, nonendotoxemic, normal saline treated (n = 10); SALINE–DEXMEDETOMIDINE, nonendotoxemic, dexmedetomidine treated (n = 10); lipopolysaccharide–SALINE, endotoxemic, normal saline treated (n = 12); lipopolysaccharide–DEXMEDETOMIDINE, endotoxemic, dexmedetomidine treated (n = 12). *P < 0.05 as compared with CONTROL, SALINE–SALINE, or SALINE–DEXMEDETOMIDINE groups. **P < 0.05 as compared with SALINE–SALINE, SALINE–DEXMEDETOMIDINE or lipopolysaccharide–SALINE groups. †P < 0.05 as compared with any other group.

Number of passing leukocytes per minute, percentage of rolling leukocytes, and number of adherent leukocytes per square millimeters on the hamster window chamber microcirculation. Data are given as means ± SD. CONTROL, baseline controls (n = 5); SALINE–SALINE, nonendotoxemic, normal saline treated (n = 10); SALINE–DEXMEDETOMIDINE, nonendotoxemic, dexmedetomidine treated (n = 10); lipopolysaccharide–SALINE, endotoxemic, normal saline treated (n = 12); lipopolysaccharide–DEXMEDETOMIDINE, endotoxemic, dexmedetomidine treated (n = 12). *P < 0.05 as compared with CONTROL, SALINE–SALINE, or SALINE–DEXMEDETOMIDINE groups. **P < 0.05 as compared with SALINE–SALINE, SALINE–DEXMEDETOMIDINE or lipopolysaccharide–SALINE groups. †P < 0.05 as compared with any other group.

Close Modal

or Create an Account

Close Modal
Close Modal